Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ketogenic diet therapy in children with epilepsy caused by SLC2A1 mutations: a single-center single-arm retrospective study.

World journal of pediatrics : WJP - 1 May 2024

Wang Ying-Yan, Zhou Yun-Qing, Luo Li-Juan, Wang Cui-Jin, Shen Nan, Li Hao, Wang Ji-Wen

Abstract excerpt

BACKGROUND: This retrospective study assessed the efficacy and safety of ketogenic diet therapies in children with epilepsy caused by SLC2A1 genetic mutations and glucose transporter type 1 deficiency syndrome. METHODS: Pediatric patients with epilepsy symptoms admitted to our medical center between January 2017 and October 2021 were included if they presented with an SLC2A1 genetic mutation on whole-exome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticonvulsants
Share to Carbohydrate Metabolism, Inborn Errors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diet, Ketogenic

Share to Epilepsy

Share to Glucose Transporter Type 1

Share to Infant

Share to Monosaccharide Transport Proteins

Share to Treatment Outcome

Source

Identifiers

PMID: 36303089
DOI: 10.1007/s12519-022-00620-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ketogenic diet therapy in children with epilepsy caused by SLC2A1 mutations: a single-center single-arm retrospective study.PMID 36303089Read ↗

Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.Semantic proximity Read ↗

Long-term effectiveness and tolerability of ketogenic diet therapy in patients with genetic developmental and epileptic encephalopathy onset within the first 6 months of life.Semantic proximity Read ↗

Glucose transporter type 1 deficiency syndrome: Phenotypes, molecular findings, and ketogenic therapy implementation in Argentina.Semantic proximity Read ↗

The Efficacy of Ketogenic Diet for Specific Genetic Mutation in Developmental and Epileptic EncephalopathySemantic proximity Read ↗

Genotype-driven therapeutics in DEE and metabolic epilepsy: navigating treatment efficacy and drug resistance.Semantic proximity Read ↗

SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures.Semantic proximity Read ↗

Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndromeSemantic proximity Read ↗

Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes.Semantic proximity Read ↗

Exploring ketogenic diet resistance in glucose transporter type 1 deficiency syndrome: A comprehensive review and critical appraisalSemantic proximity Read ↗

Efficacy and safety of a ketogenic diet in children with drug-resistant epilepsySemantic proximity Read ↗

Ketogenic diet effectiveness is superior for drug resistant epilepsy with causative genetic mutation than those without genetic etiology.Semantic proximity Read ↗

Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic dietSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.